Combating Tuberculosis and Acute Respiratory Infections in India

Tuberculosis (TB) and Acute Respiratory Infections (ARIs) remain two of India’s most pressing public health concerns. Together, they contribute significantly to morbidity and mortality, particularly affecting vulnerable populations such as children under five and immunocompromised individuals. Understanding these conditions-their causes, transmission, and prevention-is essential for healthcare professionals, especially community health nurses who serve as frontline defenders against these respiratory threats.

Understanding tuberculosis: the silent epidemic 🔗

Tuberculosis is an infectious disease caused by bacteria called Mycobacterium tuberculosis. While it most commonly affects the lungs (pulmonary TB), it can also involve other parts of the body such as the spine, brain, and kidneys. TB bacteria spread through the air when an infected person with active lung disease coughs, speaks, sneezes, or sings. People nearby may inhale these airborne droplets and become infected.

An important distinction exists between TB infection and TB disease. About a quarter of the global population is estimated to have been infected with TB bacteria, but most remain asymptomatic. Only about 5-10% of infected individuals eventually develop active TB disease. Those with latent TB infection are not contagious and do not feel sick, while those with active disease can spread the infection to others.

Common symptoms of tuberculosis 🔗

Active TB symptoms include persistent cough lasting more than two weeks, chest pain, weakness, unexplained weight loss, fever, and night sweats. In healthy individuals, the immune system can contain the bacteria, preventing symptom development. However, conditions that weaken immunity-such as HIV/AIDS, malnutrition, diabetes, or tobacco use-significantly increase the risk of infection progressing to disease.

TB burden in India: the numbers speak 🔗

India bears the world’s highest tuberculosis burden. TB incidence per 100,000 population decreased from 322 in 2000 to 195 in 2023, demonstrating substantial progress. Similarly, TB-related mortality dropped significantly during this period. India achieved a notable 17.7% decline in TB incidence from 2015 to 2023-over twice the global average decline of 8.3%.

The India TB Report 2024 revealed that 25.55 lakh TB cases were notified in 2023, the highest since the national programme’s inception. This increase in notifications is actually a positive indicator-it reflects better case detection rather than rising infections. Treatment coverage improved to 80% of estimated cases, representing a 19% increase over the previous year.

National Tuberculosis Elimination Programme (NTEP) 🔗

India’s commitment to eliminating TB is spearheaded by the National Tuberculosis Elimination Programme, renamed from the Revised National Tuberculosis Control Programme (RNTCP) in 2020. This name change reflects India’s ambitious goal to eliminate TB by 2025-five years ahead of the global Sustainable Development Goal target of 2030.

The NTEP operates under the National Strategic Plan 2017-2025, following four key pillars: Detect, Treat, Prevent, and Build. The programme conducted approximately 1.89 crore sputum smear tests and 68.3 lakh nucleic acid amplification tests in 2023. Designated Microscopy Centers increased by 80% over nine years-from 13,583 in 2014 to 24,573 in 2023.

Key NTEP initiatives 🔗

Several innovative strategies support TB elimination efforts:

Nikshay Poshan Yojana: Launched in April 2018, this scheme provides ₹500 per month as direct benefit transfer to support the nutrition of TB patients throughout their treatment. Undernutrition is a significant TB risk factor, and this initiative addresses it directly.

Pradhan Mantri TB Mukt Bharat Abhiyaan: This campaign aims to unite communities, businesses, and institutions in supporting TB patients. Over 1.6 lakh Ni-kshay Mitras (community supporters) have registered and been linked to 11.4 lakh TB patients, providing additional nutritional and social support.

Improved Drug-Resistant TB Treatment: India has introduced safer, shorter all-oral regimens for drug-resistant TB, improving success rates from 68% in 2020 to 75% in 2022.

Acute respiratory infections in children 🔗

Acute Respiratory Infections represent another significant health challenge, particularly for young children. ARIs are the leading cause of death among children less than five years in India. These infections affect the respiratory tract and range from mild upper respiratory infections like common cold to severe lower respiratory infections such as pneumonia and bronchiolitis.

India contributes the highest number of deaths due to pneumonia, accounting for about 20% of global mortality among children under five. Pneumonia is the single most important cause of death among children in the postneonatal period, responsible for approximately 27.5% of under-five mortality in the country.

Risk factors for ARIs in children 🔗

Multiple factors contribute to ARI susceptibility in children. Partial or incomplete immunization significantly increases pneumonia risk. Low birth weight is a major contributor to pneumonia morbidity, while coexisting conditions like diarrhea, measles, and severe malnutrition worsen disease severity.

Environmental factors play a crucial role. Unclean fuel sources, including biomass and charcoal, are major determinants of childhood ARI. Children living in overcrowded houses or large families are more vulnerable. Indoor smoke exposure and lack of exclusive breastfeeding during the first six months further increase risk.

Prevention strategies for TB and ARIs 🔗

BCG vaccination 🔗

The Bacille Calmette-Guérin (BCG) vaccine remains a cornerstone of childhood immunization in India. Administered at birth, this vaccine helps the immune system fight TB bacteria and prevents serious TB disease. While BCG cannot completely prevent TB infection, it prevents about 20% of infections in children, and among those who do get infected, protects approximately half from developing active disease.

BCG’s greatest protective effect is against severe forms of TB-miliary tuberculosis and TB meningitis in children. The Universal Immunization Programme recommends 0.05 ml for children under one month and 0.1 ml for older children, given intradermally.

Early detection and treatment 🔗

Seeking medical attention promptly for symptoms like prolonged cough, fever, and unexplained weight loss helps stop TB spread and improves recovery chances. For ARIs, recognizing danger signs such as rapid breathing is crucial. Studies show only 16% of mothers recognize rapid breathing as a pneumonia symptom, highlighting the need for better health education.

Improving living conditions 🔗

Environmental modifications significantly reduce respiratory infection risk. Adequate ventilation, reducing household air pollution by transitioning from solid fuels to cleaner cooking options, and avoiding overcrowding are essential measures. TB germs spread more easily in small, closed spaces with poor air circulation.

Nutrition and immunization 🔗

Addressing malnutrition is critical for both TB and ARI prevention. Well-nourished children have stronger immune responses to infections. Complete immunization significantly reduces pneumonia risk in children. The inclusion of the pentavalent vaccine (protecting against Haemophilus influenzae type b, a major pneumonia cause) in India’s national immunization schedule has helped reduce childhood pneumonia burden.

The role of community health nurses 🔗

Community health nurses serve as vital links between healthcare systems and communities. Their responsibilities include conducting health education sessions on respiratory hygiene and cough etiquette, identifying symptomatic individuals during home visits, ensuring treatment adherence through directly observed therapy, promoting vaccination coverage, and advocating for improved living conditions.

ASHA workers receive incentives under NTEP for supporting TB patients, demonstrating the value placed on community-level healthcare workers. Contact tracing-identifying and screening household members of TB patients-is another critical nursing function that helps break transmission chains.

Looking forward: challenges and opportunities 🔗

Despite significant progress, challenges remain. Drug-resistant TB poses a growing threat, requiring more complex treatment regimens. Variations in TB incidence persist across Indian states, with Delhi and Bihar showing particularly high rates. For ARIs, improving recognition of danger signs among caregivers and ensuring timely care-seeking remain priorities.

However, India’s comprehensive approach-combining strong national programmes, community engagement, nutritional support, and expanding diagnostic infrastructure-provides a robust framework for tackling these respiratory health challenges. Success will depend on sustained commitment at all levels, from policy makers to community health workers.

What do you think? How can community health nurses more effectively educate families about recognizing early warning signs of respiratory infections? What strategies might help improve treatment adherence among TB patients in your community?

References

1. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
2. https://www.cdc.gov/tb/causes/index.html
3. https://www.paho.org/en/topics/tuberculosis
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC11973646/
5. https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2070942
6. https://dghs.mohfw.gov.in/national-tuberculosis-elimination-programme.php
7. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2114549
8. https://pubmed.ncbi.nlm.nih.gov/24678190/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC10196299/
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC5846259/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC6131850/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC9174316/
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC10483089/
14. https://www.apolloclinic.com/for-patients/services/vaccinations/children/bcg
15. https://en.wikipedia.org/wiki/BCG_vaccine
16. https://www.seruminstitute.com/product_ind_tubervac.php
17. https://www.mayoclinic.org/diseases-conditions/tuberculosis/symptoms-causes/syc-20351250